The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1466
April 13, 2015
View Complete Issue         Table of Contents 2019 
Ivermectin Cream (Soolantra) for Rosacea
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Ivermectin Cream (Soolantra) for Rosacea
April 13, 2015 (Issue: 1466)
The FDA has approved a 1% cream formulation of the antiparasitic drug ivermectin (Soolantra – Galderma) for topical treatment of inflammatory lesions of rosacea. Ivermectin is available in the US in tablets (Stromectol, and generics) for...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Ivermectin Cream (Soolantra) for Rosacea
Article code: 1466a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.